相关实验视频

Updated: Sep 10, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

阿尔茨海默病研究中心唐氏综合症核心:两处地点的经验

Lauren Ptomey¹, Christy Hom², Heather Wilkins^3,4

¹Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|August 23, 2025

概括

患有唐氏综合征的人患阿尔茨海默病的风险越来越大. 为了更好地了解阿尔茨海默氏症的进展情况,

科学领域:

神经科学
遗传学
老年学

背景情况:

唐氏综合征是阿尔茨海默病的主要遗传原因,随着寿命的延长,这种疾病的流行率也在增加.
从历史上看,阿尔茨海默氏症的研究是有限的,与零星阿尔茨海默氏症相比,阻碍了对其独特的病理轨迹的理解.
国家老龄化研究所 (NIA) 支持的阿尔茨海默病研究中心 (ADRC) 网络对于解决这一研究缺口至关重要.

研究的目的:

突出两个ADRC在建立针对老龄化和AD患者的专门研究核心方面的经验.
描述这一专业研究的队列特征,结果措施和科学贡献.
在AD研究中包括患有DS的个体的挑战和机会.

主要方法:

从两个ADRC (UCI和KU) 的研究活动和队列数据的审查,重点是老化和唐氏综合征的AD.
对临床,认知,神经成像和流体生物标记数据的分析.
探讨包容性研究的经验教训和最佳实践.

主要成果:

在ADRC网络中包括患有DS的个体是可行的,对AD研究有好处.
专门的研究核心有助于全面研究阿尔茨海默氏症的进展.
涉及多发性痴呆症患者的研究对阿尔茨海默病的生物标志物和神经病理学产生了宝贵的见解.

结论:

将患有阿尔茨海默氏症的人员纳入ADRC是促进阿尔茨海默氏症研究的关键.
鼓励对患有DS的人进行临床,认知和生物标志物研究.
这项研究为扩大AD研究范围,

关键词:

唐氏综合征模块诱导多能干细胞生活方式代谢过程神经病理学神经心理学三重症 21

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Intellectual Disability

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...

Learning Disabilities

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...